Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Elizabeth M. Macy"'
Autor:
Dan L. Crimmins, Niklas Mattsson, Pashtun Shahim, Kaj Blennow, Henrik Zetterberg, Yelverton Tegner, Jack H. Ladenson, Elizabeth M. Macy
Publikováno v:
Brain Injury. 29:872-876
Visinin-like protein-1 (VILIP-1) has shown potential utility as a biomarker for neuronal injury in cerebrospinal fluid. This study investigated serum VILIP-1 as a diagnostic and prognostic marker in sports-related concussion.This multi-centre prospec
Autor:
John C. Morris, Anne M. Fagan, Jin-Moo Lee, Elizabeth M. Macy, Rawan Tarawneh, Jack H. Ladenson, Deborah Carter, Nigel J. Cairns, Gina D'Angelo, Denise Head, Chengjie Xiong, David M. Holtzman, Mark A. Mintun
Publikováno v:
Annals of Neurology. 70:274-285
Objective: There is a growing need to identify cerebrospinal fluid (CSF) markers that can detect Alzheimer's disease (AD) pathology in cognitively normal individuals because it is in this population that disease-modifying therapies may have the great
Autor:
Maartje I. Kester, Anne M. Fagan, Charlotte E. Teunissen, David M. Holtzman, Wiesje M. van der Flier, Elizabeth M. Macy, Jack H. Ladenson, Philip Scheltens, Daniel L. Crimmins, John C. Morris
Publikováno v:
Alzheimer's & Dementia. 11
Publikováno v:
Journal of child neurology. 30(10)
Children with sickle cell disease, including those without evidence for cerebral infarcts, are at increased risk for cognitive deficits that can contribute to difficulties in academic and social functioning. Chronic inflammatory processes are endemic
Autor:
Anne M. Fagan, Maartje I. Kester, David M. Holtzman, Elizabeth M. Macy, John Morris, Chengjie Xiong, Charlotte E. Teunissen, Jack H. Ladenson, Marinus A. Blankenstein, Wiesje M. van der Flier, Courtney L. Sutphen, Philip Scheltens
Publikováno v:
Alzheimer's & Dementia. 10
BIOMARKERS TO DIAGNOSE, PREDICT, AND MONITOR ALZHEIMER’S DISEASE Maartje I. Kester, Charlotte Teunissen, Courtney Sutphen, Elizabeth Macy, Jack Ladenson, Chengjie Xiong, Marinus A. Blankenstein, Philip Scheltens, Wiesje M. van der Flier, John Carl
Autor:
Timothy E. Hayes, Pamela A. Sakkinen, Elaine Cornell, Lewis H. Kuller, Elizabeth M. Macy, Russell P. Tracy, Peter W. Callas
Publikováno v:
American Journal of Epidemiology. 149:261-267
An increasing number of cardiovascular epidemiologic studies are measuring non-traditional risk markers of disease, most of which do not have established biovariability characteristics. When biovariability data have been reported, they usually repres
Autor:
Edwin G. Bovill, Russell P. Tracy, Sarah D. Nightingale, William M. Feinberg, Lesly A. Pearce, Elaine Cornell, Elizabeth M. Macy
Publikováno v:
Thrombosis and Haemostasis. 82:100-103
SummaryPlasmin-α2-antiplasmin complex (PAP) is an index of recent fibrinolytic activity. We examined PAP levels in patients with atrial fibrillation (AF) to determine whether these levels are correlated with clinical characteristics associated with
Autor:
Russell P. Tracy, Arun K. Sabharwal, Robin Boineau, Mary Cushman, Lewis H. Kuller, Pamela A. Sakkinen, Bruce M. Psaty, S. Paul Bajaj, Elizabeth M. Macy
Publikováno v:
Thrombosis and Haemostasis. 80:134-139
SummaryThe majority of fatal acute myocardial infarctions occur in the elderly. Since these events are predominantly thrombotic, we studied the cross-sectional associations of the anticoagulant proteins Anti-thrombin, Protein C, Protein S, and Tissue
Autor:
Elizabeth M. Macy, Edwin G. Bovill, Elaine S. Cornell, Mary Cushman, Russell P. Tracy, Lewis H. Kuller, Bruce M. Psaty
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 17:2167-2176
Abstract Blood levels of C-reactive protein (CRP), a marker of inflammation, are related to cardiovascular disease risk. To determine cross-sectional correlates in the elderly, we measured CRP in 400 men and women older than 65 years and free of clin
Publikováno v:
Clinical Chemistry. 43:52-58
We developed a reproducible ELISA for C-reactive protein (CRP), calibrated with WHO Reference Material, for which intra- and interassay CVs were 3.0% and 6.0%, respectively. Analytical recovery was 97.9%. The distribution of CRP in a healthy blood do